FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1785-1786 June 17, 1993 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Ballem and colleagues (Dec. 17 issue)¹ make important contributions to the understanding of human immunodeficiency virus (HIV)-related thrombocytopenia, emphasizing the role of decreased production of platelets, possibly due to viral infection of "neglected" megakaryocytes, as the accompanying editorial puts it². We studied the survival of ¹¹¹In-labeled autologous platelets in a group of intravenous drug users with HIV-related thrombocytopenia that was severe (<30 x 10³ platelets per cubic millimeter; 28 patients) or moderate (30 to 99 x 10³ platelets per cubic millimeter; 24 patients)^3,4. Although our mean results were similar to those reported by Ballem et . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lord, R. V. N., Coleman, M. J., Milliken, S. T. (1998). Splenectomy for HIV-Related Immune Thrombocytopenia: Comparison With Results of Splenectomy for Non-HIV Immune Thrombocytopenic Purpura. Arch Surg 133: 205-210 [Abstract] [Full Text]  
• Scaradavou, A., Woo, B., Woloski, B.M.R., Cunningham-Rundles, S., Ettinger, L. J., Aledort, L. M., Bussel, J. B. (1997). Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 Patients. Blood 89: 2689-2700 [Abstract] [Full Text]